Ionis Pharmaceuticals, Inc.
Climate Impact & Sustainability Data (2023)
Reporting Period: 2023
Environmental Metrics
Total Carbon Emissions:5,483 MtCO2e
Scope 1 Emissions:2,695 MtCO2e
Scope 2 Emissions:2,788 MtCO2e
Renewable Energy Share:51%
Total Energy Consumption:13,161 MWh
Water Consumption:12.85 million gallons
Waste Generated:634 tons
Carbon Intensity:6.11 tCO2e/employee in 2023
ESG Focus Areas
- Innovation and Drug Discovery
- Patient Advocacy and Engagement
- Workplace Culture
- Diversity, Equity and Inclusion
- Environmental Sustainability
- Governance and Integrity
Environmental Achievements
- Achieved 51% renewable energy use in 2023 with 17% of electricity from renewable sources generated onsite.
- 24% reduction in water use since 2021 (12.85 million gallons in 2023)
- New condensate water collection system for reuse in cooling tower at Carlsbad headquarters.
- New state-of-the-art research and development facility under construction, aiming for LEED Gold certification.
Social Achievements
- Launched Ionis VisION Awards, recognizing six outstanding employees.
- Launched new corporate DEI site and dashboard.
- Expanded employee resource groups to nine.
- 1,400+ hours of employee volunteering.
- 73% employee engagement in 2023 survey.
- Voluntary turnover rate of 5.2% (well below industry average).
Governance Achievements
- Conducted first CR materiality assessment.
- Expanded Corporate Responsibility Steering Committee.
- Over 95% of employees completed Code of Ethics and Business Conduct training.
- Hired a Data Privacy Officer and appointed a Chief Information Security and Compliance Officer.
Climate Goals & Targets
Environmental Challenges
- Increased Scope 1 and 2 GHG emissions by 18% since 2021 (despite emissions intensity per employee decreasing by 15%).
- Potential climate change-related risks including extreme weather events and regulatory changes.
Mitigation Strategies
- Investing in technology and infrastructure to reduce electricity use (solar energy systems, energy efficiency programs).
- Incorporating energy-efficient design into new facilities.
- Developing action plans to address material risks and opportunities identified in the CR materiality assessment.
- Scenario analysis planned for 2025 to evaluate impact of climate-related risks and opportunities.
Supply Chain Management
Climate-Related Risks & Opportunities
Physical Risks
- Extreme weather events
- Natural disasters
Transition Risks
- Regulatory changes
- Potential carbon tax or regulatory incentives
Reporting Standards
Frameworks Used: SASB, TCFD
Certifications: AAALAC
Awards & Recognition
- 2023 Rainwater Prize
- 2023 Drs. Ayeez and Shelena Lalji and Family ALS Endowed Award